Explore key technology breakthroughs transforming the Connected Diabetes Device Market to USD 70.4 Billion by 2035 at 12.6% CAGR.

Accelerating Technological Disruption in Connected Diabetes Devices
Technology is rapidly changing how the Connected Diabetes Device sector works. Patients and doctors want more autonomy, better connections between devices, and tools that never fail when they are needed most.
The global market was valued at USD 21.5 Billion in 2025. It is projected to reach USD 70.4 Billion by 2035, growing at a CAGR of 12.6% from 2026 to 2035. That kind of growth does not happen by accident.
For an in-depth analysis of the market, try a free sample.
Key takeaway: The future of connected diabetes care will depend less on device count and more on software agility, easy interoperability, and smart subsystems that speed up deployment.
**Connected Diabetes Device Market Value Snapshot, 2025 to 2035 (USD Billion)**
| Metric | 2025 (USD Billion) | 2035 (USD Billion) | CAGR (2026 to 2035) |
|---|---|---|---|
| Total Connected Diabetes Device Market | 21.5 | 70.4 | 12.6% |
**Hardware versus software growth signals**
| Offering Segment | Current Position | Growth Outlook |
|---|---|---|
| Device hardware (CGMs, insulin pumps, smart meters, smart pens) | 91.5% of 2025 revenue | Largest revenue base, but growing more slowly |
| Software and apps | Smaller share, rising fast | 19.0% CAGR, faster than the total market |
Source: Global Market Insights, 2026 (figures use a separate market base)
Buyers are moving away from one time hardware purchases. They now want software that can be upgraded again and again over the life of a device.
Next Generation Intelligent Systems & Edge Processing
Modern glucose sensors do much more than send a number to a screen. They combine signals from multiple inputs, filter out noise, and estimate glucose trends in real time. This process is called sensor fusion, and it makes readings more accurate.
Edge processing moves these calculations onto the device or a nearby phone. That means a warning can reach the user in seconds, even when the internet is slow or down. Faster local decisions lead to safer outcomes.
Automated insulin delivery systems show this technology at work. They read glucose data, run control algorithms, and adjust insulin doses many times each hour. Users spend less time doing math and more time living their lives.
Field results point in the same direction. Users of connected systems often report fewer severe lows and more time within their target glucose range. Clinics also see fewer urgent calls because the data arrives earlier.
Sources: official corporate technological disclosures, 2025/2026.
Advanced Engineering & High Efficiency Infrastructure
Device makers now use stronger, lighter materials in sensors, pumps, and wearable patches. These materials help the products stay comfortable on the skin for longer periods. They also handle heat, moisture, and daily movement better.
Battery design is another major focus. Engineers are building low power chips that can run for weeks on a single charge. Less charging means fewer interruptions for users who depend on constant monitoring.
Longevity matters just as much as comfort. Sensors that last longer mean fewer replacements, less waste, and lower costs for health systems. Companies also design parts that are easier to test and swap out.
Operational readiness is measured in simple ways. Teams track how often devices fail, how long they stay accurate, and how quickly support teams can fix problems. Each improvement cuts downtime for patients and providers.
Sources: official industry standards and technical disclosures, 2026.
"Connected data is no longer a nice extra. It is the baseline for safe, effective diabetes care." (Interpretation of findings from a 2024 Norwegian study on diabetes device data access, PMC11954377)"
Connected Intelligence & Distributed Enterprise Architectures
Devices now send data to cloud platforms, phone apps, and clinic systems. Strong security protects this flow from hackers and accidental leaks. Encryption and strict access rules keep private health data safe.
Real time orchestration makes sure the right person sees the right alert. A parent, a nurse, and a doctor may each receive different updates. Each update is shaped by the user's settings and care plan.
Interoperability remains the biggest hurdle. A study of diabetes tools in Norway found seven devices and nine regulated software solutions. Only one offered a publicly accessible API, which shows how limited data sharing still is.
Open source projects and do it yourself communities have pushed for better access. They build tools that let patients see their own data in new ways. However, they often face technical and legal barriers that slow them down.
Sources: regulatory filings and enterprise disclosures, 2026.
Predictive Diagnostics & AI Driven Lifecycle Modernization
Predictive algorithms now spot patterns before problems grow. They can flag a sensor that is drifting or a pump that needs service. Early alerts help teams act before users feel any impact.
Digital twins are virtual copies of devices and care settings. Teams test software updates on these copies before pushing them to real users. This lowers risk and speeds up improvements.
Supply chain data also plays a big role. Real time tracking helps manufacturers avoid shortages of sensors, pumps, and test strips. Steady supply keeps patients from going without the tools they need.
These gains add up quickly. Fewer device failures mean better uptime for patients and fewer emergency visits. Smarter buying also helps health systems control costs over time.
Sources: official corporate and logistics disclosures, 2026.
Strategic Outlook: Roadmap to 2035
The next decade will reward companies that plan for change. Leaders should invest in software platforms that can grow with the device. They should also build secure data pipelines that work with many partners.
Technology providers have a role to play too. Open standards and public APIs will help patients move their data across tools. Clear rules on privacy and safety will build trust with users and regulators.
Collaboration is now a must. Device makers, app developers, clinics, and insurers need to work from the same playbook. Shared goals will speed up approvals and make care more consistent.
Report ID: HII-CD6C15F0
